ü¿ÜÁø´Ü ¼¼°è ½ÃÀåÀº 2030³â±îÁö 1,343¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á
2023³â¿¡ 1,062¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ü¿ÜÁø´Ü ¼¼°è ½ÃÀåÀº ºÐ¼®±â°£ 2023-2030³â¿¡ CAGR 3.4%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 1,343¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼¿¡¼ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ½Ã¾à¡¤Å°Æ®´Â CAGR 3.3%¸¦ ±â·ÏÇÏ°í, ºÐ¼®±â°£ Á¾·á½Ã¿¡´Â 863¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±â±â ºÐ¾ßÀÇ ¼ºÀåÀº ÇâÈÄ 7³â°£ CAGRÀÌ 4%·Î ÃßÁ¤µË´Ï´Ù.
¹Ì±¹ ½ÃÀåÀº 283¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 5.2%·Î ¼ºÀå ¿¹Ãø
¹Ì±¹ÀÇ Ã¼¿ÜÁø´Ü ½ÃÀåÀº 2023³â¿¡´Â 283¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 271¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2023³âºÎÅÍ 2030³â±îÁö ºÐ¼®±â°£ CAGRÀº 5.2%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, °¢°¢ 2023³âºÎÅÍ 2030³â±îÁö 2.3%¿Í 2.7%ÀÇ ¼ºÀåÀÌ ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼´Â µ¶ÀÏÀÌ CAGR ¾à 2.6%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. È£ÁÖ, Àεµ, Çѱ¹ µîÀÇ ±¹°¡°¡ °ßÀÎÇÏ´Â ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½ÃÀåÀº 2030³â±îÁö 176¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
2024³â¿¡ »õ·Ó°Ô ¼±º¸ÀÌ´Â Èï¹Ì·Î¿î º¸°í¼ ±â´É ¼Ò°³
ÀÎÇ÷ç¾ð¼ Âü¿© Åë°è¿¡ ´ëÇÑ Ç® ¾×¼¼½º
µðÁöÅÐ ¾ÆÄ«À̺ê¿Í "MarketGlass" Á¶»ç Ç÷§Æû¿¡ ¹«·á·Î ¾×¼¼½ºÇÒ ¼ö ÀÖ½À´Ï´Ù. ´ç»çÀÇ µ¶ÀÚÀûÀÎ MarketGlass Ç÷§ÆûÀº Àü ¼¼°è Àü¹®°¡µéÀÇ Ã¢ÀǼº°ú ½ÃÀå Áö½ÄÀ» ÅëÇÕÀûÀÌ°í Çù·ÂÀûÀ¸·Î ¹ßÈÖÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÕ´Ï´Ù. ´ç»çÀÇ ÃÖ÷´Ü µµ±¸´Â ½ÃÀå ÁøÀÔÀÚÀÇ ÇÁ¶óÀ̹ö½Ã¿Í ½Å¿øÀ» º¸È£ÇÏ¸é¼ ¼¼°èÀû ¼öÁØÀÇ ½ÃÀå Àü¸ÁÀ» Á¦°øÇÕ´Ï´Ù. º¸°í¼ÀÇ ¼öÄ¡, Åë°è ¹× ½ÃÀå ¼³¸íÀº ÀÌ ºÐ¾ßÀÇ Àü¹®°¡¿Í ¿µÇâ·Â ÀÖ´Â »ç¶÷µéÀÌ °øÀ¯ÇÑ ¿ÏÀüÈ÷ ¼±º°µÈ ÀλçÀÌÆ®¸¦ ±â¹ÝÀ¸·Î ÇÕ´Ï´Ù.
½Ç½Ã°£ µ¥ÀÌÅÍ ½Ã¹Ä·¹ÀÌÅÍ µµ±¸¿Í ¸ÂÃãÇü º¸°í¼ ÀÛ¼º ±â´ÉÀ» °®Ãá ÀÎÅÍ·¢Æ¼ºê ¼³¹® Á¶»ç¿¡ Âü¿©ÇÒ ¼ö ÀÖ½À´Ï´Ù.
±â¾÷ °£ ½º¸¶Æ®ÇÑ ÀÇ°ß ±³È¯À» À§ÇÑ ÇǾî Çù¾÷ ÀÎÅÍ·¢Æ¼ºê Ç÷§Æû¿¡ ´ëÇÑ Ç® Ŭ¶óÀ̾ðÆ® ¾×¼¼½º
1³â°£ ¹«·á º¸°í¼ ¾÷µ¥ÀÌÆ®
ÁÖ¿ä ±â¾÷ÀÇ ¼¼°è ½ÃÀå Á¡À¯À²À» Æ÷ÇÔÇÑ °æÀï Ä¿¹ö¸®Áö
¿©·¯ Áö¿ª¿¡ °ÉÄ£ ±â¾÷ÀÇ ½ÃÀå ÀÔÁö ºÐ¼®(È£Á¶/È°¹ß/Æ´»õ/¸¶À̳Ê)
Àü¹®°¡/ÀÎÇ÷ç¾ð¼ ÀÎÅͺä, ÆÌij½ºÆ®, ¾ð·Ð ¹ßÇ¥, À̺¥Æ® ±âÁ¶¿¬¼³ À¯Æ©ºê µ¿¿µ»ó¿¡ ´ëÇÑ Á¢±Ù¼º
2024³â ¼¼°è °æÁ¦¿¡ ´ëÇÑ ±â´ë
ÅëÈ ±äÃà°ú ÀÌ¿¡ µû¸¥ ±Ý¸® »ó½ÂÀ¸·Î ÀÎÇÑ ÁöÁ¤ÇÐÀû, °æÁ¦Àû ºÒ¾ÈÁ¤¼ºÀÌ 2024³â °Ýµ¿ÀûÀÎ »óȲÀ» ¸¸µé¾î ³¾ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. Áßµ¿ÀÇ Àû´ë ÇàÀ§¿Í Á¡Á¡ ´õ Àæ¾ÆÁö´Â ±âÈÄ ÀçÇØ µî ¿©·¯ ¿äÀεéÀÌ È¸º¹ÀÇ ±æ¿¡ °è¼Ó ¾Ð·ÂÀ» °¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À§Çè¿äÀÎÀÌ ÀÖ´Â ¹Ý¸é, µðÇ÷¹ÀÌ¼Ç Á¶ÁüÀÌ °ÇØÁö°í, ¿Ï°íÇÑ ÀÎÇ÷¹À̼ǿ¡ ´ëÇÑ ºÒ¾È°¨ÀÌ ¿Ïȵǰí, °ø±Þ¸ÁÀÌ Á¤»óȵǰí, ¿¡³ÊÁö ºñ¿ë º¯µ¿¿¡µµ ºÒ±¸ÇÏ°í ¹°°¡°¡ ¿Ï¸¸ÇÏ°Ô »ó½ÂÇÏ´Â µî ¸î °¡Áö ±àÁ¤ÀûÀÎ ¿äÀεµ ³ªÅ¸³ª°í ÀÖ½À´Ï´Ù. Àεµ¿Í ¹Ì±¹À» ºñ·ÔÇÑ G21 ±¹°¡µéÀÇ ¼±°Å´Â ÀÚº» È帧°ú ÅõÀÚ Àü·«¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. Àεµ°¡ ±Û·Î¹ú ÅõÀÚó·Î ÁÖ¸ñ¹Þ°í ÀÖ´Â °¡¿îµ¥, ¹Ì±¹¿¡ ±â¹ÝÀ» µÐ ÇÏÀÌÅ×Å© ±â¾÷µéÀº ¿ªµ¿ÀûÀÎ ÀÎÀç¿Í ÀÚº» »ýÅ°迡 ÈûÀÔ¾î °è¼Ó ¿ìÀ§¸¦ Á¡ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ½Ç¸®Äܹ븮¸¦ ºñ·ÔÇÑ ÇÏÀÌÅ×Å© ±âȸ´Â ±¹³» °æÁ¦°¡ µÐȵDZä ÇßÁö¸¸ ¿©ÀüÈ÷ °ß°íÇÏ°í ±ÔÁ¦ ȯ°æÀÌ Àß Á¤ºñµÇ¾î ÀÖ¾î ³ôÀº ¼ºÀå ÀáÀç·ÂÀ» Ãß±¸ÇÏ´Â ÅõÀÚÀڵ鿡°Ô ¿©ÀüÈ÷ ¸Å·ÂÀûÀÏ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. À¯·´Àº ±äÃàÁ¤Ã¥°ú °æ±âħü ¸®½ºÅ©¿ÍÀÇ ½Î¿òÀÌ °è¼ÓµÇ°í ÀÖÀ¸¸ç, ¿µ±¹Àº 2024³â °æ±âħü ¸®½ºÅ©°¡ °¡Àå ³ôÀº ±¹°¡·Î °¡Àå ¾î·Á¿î Àü¸ÁÀ» º¸ÀÌ°í ÀÖ½À´Ï´Ù. Áß±¹Àº Á¤ºÎ ÁöÃâ°ú °³ÀÎ ¼Òºñ °³¼±¿¡ ÈûÀÔ¾î ¼ºÀå¼¼¸¦ À̾ °ÍÀ¸·Î ¿¹»óµÇ´Â ¿ÍÀϵåÄ«µå°¡ µÉ °ÍÀÔ´Ï´Ù. ºÒ¾ÈÁ¤ÇÑ È¯°æÀº ÅõÀÚÀÚ¿Í ±â¾÷ ¸ðµÎ¿¡°Ô ±âȸ¿Í µµÀüÀ» µ¿½Ã¿¡ °¡Á®´Ù ÁÙ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. º¯µ¿¼ºÀ» ¼ºÀåÀÇ Ã˸ÅÁ¦·Î ¹Þ¾ÆµéÀÌ°í, ¹ÎøÇÑ ÅõÀÚ ÆÇ´Ü°ú Àü·«Àû ¼±°ßÁö¸íÀÌ »ýÁ¸À» À§ÇÑ ÇÙ½É ¿ä¼Ò·Î ÀÛ¿ëÇÒ °ÍÀÔ´Ï´Ù.
Á¶»ç ´ë»ó ±â¾÷ »ç·Ê(ÁÖ¸ñ 58°³»ç)
- Abbott Laboratories
- Agilent Technologies, Inc.
- Becton, Dickinson & Company
- bioMerieux SA
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- DiaSorin SpA
- Johnson & Johnson
- Ortho Clinical Diagnostics
- Qiagen NV
- Roche Diagnostics(Schweiz) AG
- Siemens AG
- Sysmex Corporation
- Thermo Fisher Scientific, Inc.
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý
Á¦2Àå ÁÖ¿ä ¿ä¾à
- ½ÃÀå °³¿ä
- ÁÖ¿ä ±â¾÷
- ½ÃÀå µ¿Çâ°ú ¼ºÀå ÃËÁø¿äÀÎ
- ¼¼°è ½ÃÀå Àü¸Á
Á¦3Àå ½ÃÀå ºÐ¼®
- ¹Ì±¹
- ij³ª´Ù
- ÀϺ»
- Áß±¹
- À¯·´
- ÇÁ¶û½º
- µ¶ÀÏ
- ÀÌÅ»¸®¾Æ
- ¿µ±¹
- ½ºÆäÀÎ
- ·¯½Ã¾Æ
- ±âŸ À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- È£ÁÖ
- Àεµ
- Çѱ¹
- ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¶óƾ¾Æ¸Þ¸®Ä«
- ¾Æ¸£ÇîƼ³ª
- ºê¶óÁú
- ¸ß½ÃÄÚ
- ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
- 秵- À̶õ
- À̽º¶ó¿¤
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®
- ±âŸ Áßµ¿
- ¾ÆÇÁ¸®Ä«
Á¦4Àå °æÀï
KSM 24.05.21
Global In Vitro Diagnostics Market to Reach $134.3 Billion by 2030
The global market for In Vitro Diagnostics estimated at US$106.2 Billion in the year 2023, is expected to reach US$134.3 Billion by 2030, growing at a CAGR of 3.4% over the analysis period 2023-2030. Reagents & Kits, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$86.3 Billion by the end of the analysis period. Growth in the Instruments segment is estimated at 4% CAGR for the next 7-year period.
The U.S. Market is Estimated at $28.3 Billion, While China is Forecast to Grow at 5.2% CAGR
The In Vitro Diagnostics market in the U.S. is estimated at US$28.3 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$27.1 Billion by the year 2030 trailing a CAGR of 5.2% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.3% and 2.7% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$17.6 Billion by the year 2030.
Introducing Our Exciting New Report Features for 2024
Full access to influencer engagement stats
Free access to our digital archives & "MarketGlass" research platform. Our proprietary MarketGlass platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. Our state-of-art tools bring world class market perspectives while protecting participants' privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.
Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities
Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas
Complimentary report updates for one year
Competitor coverage with global market shares of major players
Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies
Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes
What to Expect from the Global Economy in 2024
Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.
Select Competitors (Total 58 Featured) -
- Abbott Laboratories
- Agilent Technologies, Inc.
- Becton, Dickinson & Company
- bioMerieux SA
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- DiaSorin SpA
- Johnson & Johnson
- Ortho Clinical Diagnostics
- Qiagen NV
- Roche Diagnostics (Schweiz) AG
- Siemens AG
- Sysmex Corporation
- Thermo Fisher Scientific, Inc.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
- 1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Global Economic Update
- In Vitro Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
- 2. FOCUS ON SELECT PLAYERS
- 3. MARKET TRENDS & DRIVERS
- 4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World In Vitro Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for In Vitro Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 3: World Historic Review for In Vitro Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 4: World 16-Year Perspective for In Vitro Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 6: World Historic Review for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 7: World 16-Year Perspective for Reagents & Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 9: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 10: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for Data Management Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 12: World Historic Review for Data Management Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 13: World 16-Year Perspective for Data Management Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 15: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 16: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Immunoassay / Immunochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 18: World Historic Review for Immunoassay / Immunochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 19: World 16-Year Perspective for Immunoassay / Immunochemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 20: World Recent Past, Current & Future Analysis for Clinical Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 21: World Historic Review for Clinical Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 22: World 16-Year Perspective for Clinical Chemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 23: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 24: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 25: World 16-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 26: World Recent Past, Current & Future Analysis for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 27: World Historic Review for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 28: World 16-Year Perspective for Hematology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 29: World Recent Past, Current & Future Analysis for Microbiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 30: World Historic Review for Microbiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 31: World 16-Year Perspective for Microbiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 32: World Recent Past, Current & Future Analysis for Coagulation & Hemostasis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 33: World Historic Review for Coagulation & Hemostasis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 34: World 16-Year Perspective for Coagulation & Hemostasis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 35: World Recent Past, Current & Future Analysis for Urinalysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 36: World Historic Review for Urinalysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 37: World 16-Year Perspective for Urinalysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 38: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 39: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 40: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 41: World Recent Past, Current & Future Analysis for Hospital Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 42: World Historic Review for Hospital Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 43: World 16-Year Perspective for Hospital Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 44: World Recent Past, Current & Future Analysis for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 45: World Historic Review for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 46: World 16-Year Perspective for Clinical Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 47: World Recent Past, Current & Future Analysis for Point-Of-Care Testing Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 48: World Historic Review for Point-Of-Care Testing Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 49: World 16-Year Perspective for Point-Of-Care Testing Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 50: World Recent Past, Current & Future Analysis for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 51: World Historic Review for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 52: World 16-Year Perspective for Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 53: World Recent Past, Current & Future Analysis for Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 54: World Historic Review for Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 55: World 16-Year Perspective for Patients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- TABLE 56: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 57: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 58: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
- UNITED STATES
- In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- TABLE 59: USA Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 60: USA Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 61: USA 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2024 & 2030
- TABLE 62: USA Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 63: USA Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 64: USA 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 65: USA Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 66: USA Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 67: USA 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2024 & 2030
- CANADA
- TABLE 68: Canada Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 69: Canada Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 70: Canada 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2024 & 2030
- TABLE 71: Canada Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 72: Canada Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 73: Canada 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 74: Canada Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 75: Canada Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 76: Canada 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2024 & 2030
- JAPAN
- In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- TABLE 77: Japan Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 78: Japan Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 79: Japan 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2024 & 2030
- TABLE 80: Japan Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 81: Japan Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 82: Japan 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 83: Japan Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 84: Japan Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 85: Japan 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2024 & 2030
- CHINA
- In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- TABLE 86: China Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 87: China Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 88: China 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2024 & 2030
- TABLE 89: China Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 90: China Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 91: China 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 92: China Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 93: China Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 94: China 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2024 & 2030
- EUROPE
- In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- TABLE 95: Europe Recent Past, Current & Future Analysis for In Vitro Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 96: Europe Historic Review for In Vitro Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 97: Europe 16-Year Perspective for In Vitro Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
- TABLE 98: Europe Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 99: Europe Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 100: Europe 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2024 & 2030
- TABLE 101: Europe Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 102: Europe Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 103: Europe 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 104: Europe Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 105: Europe Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 106: Europe 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2024 & 2030
- FRANCE
- In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- TABLE 107: France Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 108: France Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 109: France 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2024 & 2030
- TABLE 110: France Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 111: France Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 112: France 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 113: France Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 114: France Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 115: France 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2024 & 2030
- GERMANY
- In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- TABLE 116: Germany Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 117: Germany Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 118: Germany 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2024 & 2030
- TABLE 119: Germany Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 120: Germany Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 121: Germany 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 122: Germany Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 123: Germany Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 124: Germany 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2024 & 2030
- ITALY
- TABLE 125: Italy Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 126: Italy Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 127: Italy 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2024 & 2030
- TABLE 128: Italy Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 129: Italy Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 130: Italy 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 131: Italy Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 132: Italy Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 133: Italy 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2024 & 2030
- UNITED KINGDOM
- In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- TABLE 134: UK Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 135: UK Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 136: UK 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2024 & 2030
- TABLE 137: UK Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 138: UK Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 139: UK 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 140: UK Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 141: UK Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 142: UK 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2024 & 2030
- SPAIN
- TABLE 143: Spain Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 144: Spain Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 145: Spain 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2024 & 2030
- TABLE 146: Spain Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 147: Spain Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 148: Spain 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 149: Spain Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 150: Spain Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 151: Spain 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2024 & 2030
- RUSSIA
- TABLE 152: Russia Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 153: Russia Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 154: Russia 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2024 & 2030
- TABLE 155: Russia Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 156: Russia Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 157: Russia 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 158: Russia Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 159: Russia Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 160: Russia 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2024 & 2030
- REST OF EUROPE
- TABLE 161: Rest of Europe Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 162: Rest of Europe Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 163: Rest of Europe 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2024 & 2030
- TABLE 164: Rest of Europe Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 165: Rest of Europe Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 166: Rest of Europe 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 167: Rest of Europe Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 168: Rest of Europe Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 169: Rest of Europe 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2024 & 2030
- ASIA-PACIFIC
- In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- TABLE 170: Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 171: Asia-Pacific Historic Review for In Vitro Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 172: Asia-Pacific 16-Year Perspective for In Vitro Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
- TABLE 173: Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 174: Asia-Pacific Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 175: Asia-Pacific 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2024 & 2030
- TABLE 176: Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 177: Asia-Pacific Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 178: Asia-Pacific 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 179: Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 180: Asia-Pacific Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 181: Asia-Pacific 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2024 & 2030
- AUSTRALIA
- In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
- TABLE 182: Australia Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 183: Australia Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 184: Australia 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2024 & 2030
- TABLE 185: Australia Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 186: Australia Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 187: Australia 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 188: Australia Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 189: Australia Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 190: Australia 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2024 & 2030
- INDIA
- In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
- TABLE 191: India Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 192: India Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 193: India 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2024 & 2030
- TABLE 194: India Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 195: India Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 196: India 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 197: India Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 198: India Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 199: India 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2024 & 2030
- SOUTH KOREA
- TABLE 200: South Korea Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 201: South Korea Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 202: South Korea 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2024 & 2030
- TABLE 203: South Korea Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 204: South Korea Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 205: South Korea 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 206: South Korea Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 207: South Korea Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 208: South Korea 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2024 & 2030
- REST OF ASIA-PACIFIC
- TABLE 209: Rest of Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 210: Rest of Asia-Pacific Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 211: Rest of Asia-Pacific 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2024 & 2030
- TABLE 212: Rest of Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 213: Rest of Asia-Pacific Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 214: Rest of Asia-Pacific 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 215: Rest of Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 216: Rest of Asia-Pacific Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 217: Rest of Asia-Pacific 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2024 & 2030
- LATIN AMERICA
- In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
- TABLE 218: Latin America Recent Past, Current & Future Analysis for In Vitro Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 219: Latin America Historic Review for In Vitro Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 220: Latin America 16-Year Perspective for In Vitro Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
- TABLE 221: Latin America Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 222: Latin America Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 223: Latin America 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2024 & 2030
- TABLE 224: Latin America Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 225: Latin America Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 226: Latin America 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 227: Latin America Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 228: Latin America Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 229: Latin America 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2024 & 2030
- ARGENTINA
- TABLE 230: Argentina Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 231: Argentina Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 232: Argentina 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2024 & 2030
- TABLE 233: Argentina Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 234: Argentina Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 235: Argentina 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 236: Argentina Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 237: Argentina Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 238: Argentina 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2024 & 2030
- BRAZIL
- TABLE 239: Brazil Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 240: Brazil Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 241: Brazil 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2024 & 2030
- TABLE 242: Brazil Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 243: Brazil Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 244: Brazil 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 245: Brazil Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 246: Brazil Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 247: Brazil 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2024 & 2030
- MEXICO
- TABLE 248: Mexico Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 249: Mexico Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 250: Mexico 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2024 & 2030
- TABLE 251: Mexico Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 252: Mexico Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 253: Mexico 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 254: Mexico Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 255: Mexico Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 256: Mexico 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2024 & 2030
- REST OF LATIN AMERICA
- TABLE 257: Rest of Latin America Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 258: Rest of Latin America Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 259: Rest of Latin America 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2024 & 2030
- TABLE 260: Rest of Latin America Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 261: Rest of Latin America Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 262: Rest of Latin America 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 263: Rest of Latin America Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 264: Rest of Latin America Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 265: Rest of Latin America 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2024 & 2030
- MIDDLE EAST
- In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
- TABLE 266: Middle East Recent Past, Current & Future Analysis for In Vitro Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 267: Middle East Historic Review for In Vitro Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 268: Middle East 16-Year Perspective for In Vitro Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
- TABLE 269: Middle East Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 270: Middle East Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 271: Middle East 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2024 & 2030
- TABLE 272: Middle East Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 273: Middle East Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 274: Middle East 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 275: Middle East Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 276: Middle East Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 277: Middle East 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2024 & 2030
- IRAN
- TABLE 278: Iran Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 279: Iran Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 280: Iran 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2024 & 2030
- TABLE 281: Iran Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 282: Iran Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 283: Iran 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 284: Iran Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 285: Iran Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 286: Iran 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2024 & 2030
- ISRAEL
- TABLE 287: Israel Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 288: Israel Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 289: Israel 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2024 & 2030
- TABLE 290: Israel Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 291: Israel Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 292: Israel 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 293: Israel Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 294: Israel Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 295: Israel 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2024 & 2030
- SAUDI ARABIA
- TABLE 296: Saudi Arabia Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 297: Saudi Arabia Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 298: Saudi Arabia 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2024 & 2030
- TABLE 299: Saudi Arabia Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 300: Saudi Arabia Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 301: Saudi Arabia 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 302: Saudi Arabia Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 303: Saudi Arabia Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 304: Saudi Arabia 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2024 & 2030
- UNITED ARAB EMIRATES
- TABLE 305: UAE Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 306: UAE Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 307: UAE 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2024 & 2030
- TABLE 308: UAE Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 309: UAE Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 310: UAE 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 311: UAE Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 312: UAE Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 313: UAE 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2024 & 2030
- REST OF MIDDLE EAST
- TABLE 314: Rest of Middle East Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 315: Rest of Middle East Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 316: Rest of Middle East 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2024 & 2030
- TABLE 317: Rest of Middle East Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 318: Rest of Middle East Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 319: Rest of Middle East 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 320: Rest of Middle East Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 321: Rest of Middle East Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 322: Rest of Middle East 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2024 & 2030
- AFRICA
- In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
- TABLE 323: Africa Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 324: Africa Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 325: Africa 16-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2014, 2024 & 2030
- TABLE 326: Africa Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 327: Africa Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 328: Africa 16-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 329: Africa Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 330: Africa Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 331: Africa 16-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2014, 2024 & 2030
IV. COMPETITION